ACTIVE

ImmuneSpec

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-201,7 k €-158,9 %over 1 year
Gross margin883,6 k €+26,8 %over 1 year
Equity2,6 M €+12,7 %over 1 year
Workforce5,7 ETP+67,6 %over 1 year

Identity

Source · BCE/KBO

ImmuneSpec is a Private limited company incorporated in 2023. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Niel. It employs on average 5,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0797.707.610
Incorporation
27/01/2023
Legal form
Private limited company
Registered office
Galileilaan 18 box 6
2845 Niel · FlandreSee on map
Contributed capital
3 315 110,00 €
Latest accounts
31/12/2025
Average workforce
5,7 ETP
Joint committees (4)
  • 116
  • 1160
  • 207
  • 2070
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 3 filings

Trend over 3 financial years

202520242023
Income statement
Gross margin883,6 k €696,9 k €51,5 k €
EBITDA506,4 k €490,1 k €-28,9 k €
Operating result-177,7 k €-46,4 k €-373 k €
Net result-201,7 k €-77,9 k €-397,1 k €
Balance sheet
Equity2,6 M €2,3 M €1,9 M €
Total assets3,5 M €3,2 M €3,2 M €
Cash191,9 k €113,3 k €238,7 k €
Debts829 k €759,4 k €927,6 k €
Other
Workforce5,7 ETP3,4 ETP1,7 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 4 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Clean Vision Invest0778.490.029Represented by Bart Swaelens
Directorsince 21/12/2023
Thibault Jonckheere
Directorsince 06/11/2023
Heran Partners0744.757.486Represented by Geoffrey D'hondt
Directorsince 14/03/2023
Elise Pepermans
Directorsince 26/01/2023

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Heran HealthTech Fund I0747.662.241Represented by Kathleen Vandersmissen
Director20/03/2023 → 13/04/2023
VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK0244.195.916Represented by Robert Fabry
Director20/03/2023 → 21/12/2023
Geert Baggerman
Director26/01/2023 → 2023 accounts
Kurt Boonen
Director26/01/2023 → 20/03/2023

Other companies at this address

Galileilaan 18 2845 Niel
CompanyCBE no.
Administratiekantoor iFlux● Active
0727.509.106
iFLUX● Active
0683.854.156
Leonhard● Active
0797.304.762
MENDES● Active
0797.303.673
NIEUWE MEDIA GROEP● Active
0454.028.888
PM GROUP BELGIUM● Active
0878.160.301
PM GROUP BELGIUM SERVICES● Active
0897.585.837
Rodolphe● Active
0797.303.970
UNITED CONSULTING● Active
0464.943.467
Vereniging van Mede-eigenaars van het gebouw Residentie Archimedesgebouw Galileilaan 18 te Niel● Active
0726.823.968
XPAND● Active
0674.829.691

Full financial information

Source · NBB
202520242023
Type of accountAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202427/01/2023
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months12 months
Filing date08/06/202628/05/202511/06/2024
General meeting04/06/202627/05/202506/06/2024
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 3 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202504/06/202608/06/2026DutchPDF
Abridged model31/12/202427/05/202528/05/2025DutchPDF
Abridged model31/12/202306/06/202411/06/2024DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 4 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Clean Vision Invest0778.490.029Represented by Bart Swaelens
Directorsince 21/12/2023
Thibault Jonckheere
Directorsince 06/11/2023
Heran Partners0744.757.486Represented by Geoffrey D'hondt
Directorsince 14/03/2023
Elise Pepermans
Directorsince 26/01/2023

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Heran HealthTech Fund I0747.662.241Represented by Kathleen Vandersmissen
Director20/03/2023 → 13/04/2023
VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK0244.195.916Represented by Robert Fabry
Director20/03/2023 → 21/12/2023
Geert Baggerman
Director26/01/2023 → 2023 accounts
Kurt Boonen
Director26/01/2023 → 20/03/2023

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates06/05/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares24/03/2025
    KAPITAAL - AANDELEN
    PDF
  • Mandates19/09/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares06/06/2024
    KAPITAAL - AANDELEN
    PDF
  • Mandates28/03/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office22/06/2023
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates15/06/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates23/03/2023
    DIVERSEN - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings3 filings
Mandates
Clean Vision Invest
Thibault Jonckheere
Heran Partners
Elise Pepermans
VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK
Heran HealthTech Fund I
Geert Baggerman
Kurt Boonen
2023202420252026
ImmuneSpec
Galileilaan 18 bte 6, 2845 Niel
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Galileilaan 18 bte 6, 2845 NielCurrent
accounts 2025
Accounts 2025 · 2026-00146376
Galileilaan 18 bus 006, 2845 Niel
accounts 2024
Accounts 2024 · 2025-00108610
Galileilaan 18 bte bus 6, 2845 Niel
accounts 2023
Accounts 2023 · 2024-00128878

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
ImmuneSpecCurrent
accounts 2023 → 2025
Accounts 2025 · 2026-00146376

Events

  1. 2025
    Annual accounts 2025-201,7 k €↓
  2. 2024
    Annual accounts 2024-77,9 k €↑
  3. 2023
    Annual accounts 2023-397,1 k €
  4. 27/01/2023
    IncorporationPrivate limited company